Expert Opinion on Therapeutic Targets, Volume 20, Issue 7 (2016)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Therapeutic Targets, Volume 20, Issue 7 (2016)

See all volumes and issues
Vol 28, 2024 Vol 27, 2023 Vol 26, 2022 Vol 25, 2021 Vol 24, 2020 Vol 23, 2019 Vol 22, 2018 Vol 21, 2017 Volume 20, 2016 Vol 19, 2015 Vol 18, 2014 Vol 17, 2013 Vol 16, 2012 Vol 15, 2011 Vol 14, 2010 Vol 13, 2009 Vol 12, 2008 Vol 11, 2007 Vol 10, 2006 Vol 9, 2005 Vol 8, 2004 Vol 7, 2003 Vol 6, 2002 Vol 5, 2001 Vol 5, 2001 Vol 4, 2000 Vol 3, 1999 Vol 2, 1998 Vol 1, 1997
Download citations Download PDFs Download issue

Editorial

Editorial
Early evidence for the role of TRIM29 in multiple cancer models
Shigetsugu Hatakeyama
Pages: 767-770
Published online: 15 Feb 2016
First Page PreviewforEarly evidence for the role of TRIM29 in multiple cancer models | Full Text | References | PDF (492.7 KB)
  • 2514 Views
  • 25 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A)
Qi Fu, Yong Du, Chun Yang, Dong Zhang, Ningmei Zhang, Xiaoming Liu, William C. Cho & Yinxue Yang
Pages: 771-782
Published online: 11 May 2016
AbstractforAn oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A) | Full Text | References | PDF (1.8 MB) | Supplemental
  • 210 Views
  • 39 CrossRef citations
  • 0Altmetric

Review

Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs
Kathy A. Gelato, David Adler, Matthias Ocker & Bernard Haendler
Pages: 783-799
Published online: 22 Jan 2016
AbstractforTargeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs | Full Text | References | PDF (1.5 MB)
  • 1135 Views
  • 40 CrossRef citations
  • 0Altmetric
Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies
Margaritis Avgeris & Andreas Scorilas
Pages: 801-818
Published online: 04 Mar 2016
AbstractforKallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies | Full Text | References | PDF (1.3 MB)
  • 832 Views
  • 31 CrossRef citations
  • 0Altmetric
On the horizon: trophic peptide growth factors as therapy for neonatal short bowel syndrome
David W. Lim, Paul W. Wales, Justine M. Turner, David L. Bigam & Patricia L. Brubaker
Pages: 819-830
Published online: 01 Mar 2016
AbstractforOn the horizon: trophic peptide growth factors as therapy for neonatal short bowel syndrome | Full Text | References | PDF (990.5 KB)
  • 372 Views
  • 8 CrossRef citations
  • 0Altmetric
K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?
Ruth Nussinov, Serena Muratcioglu, Chung-Jung Tsai, Hyunbum Jang, Attila Gursoy & Ozlem Keskin
Pages: 831-842
Published online: 12 Feb 2016
AbstractforK-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target? | Full Text | References | PDF (1.6 MB)
  • 688 Views
  • 28 CrossRef citations
  • 0Altmetric
Epigenetic regulation of gene expression and M2 macrophage polarization as new potential omega-3 polyunsaturated fatty acid targets in colon inflammation and cancer
Simona Serini, Renata Ottes Vasconcelos, Elena Fasano & Gabriella Calviello
Pages: 843-858
Published online: 07 Feb 2016
AbstractforEpigenetic regulation of gene expression and M2 macrophage polarization as new potential omega-3 polyunsaturated fatty acid targets in colon inflammation and cancer | Full Text | References | PDF (1.5 MB)
  • 559 Views
  • 26 CrossRef citations
  • 0Altmetric
Molecular targets on B-cells to prevent and treat antibody-mediated rejection in organ transplantation. Present and Future
Jose A. Galián, Anna Mrowiec & Manuel Muro
Pages: 859-867
Published online: 10 Feb 2016
AbstractforMolecular targets on B-cells to prevent and treat antibody-mediated rejection in organ transplantation. Present and Future | Full Text | References | PDF (930.8 KB)
  • 504 Views
  • 15 CrossRef citations
  • 0Altmetric
Club Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD)
Maria E. Laucho-Contreras, Francesca Polverino, Yohannes Tesfaigzi, Aprile Pilon, Bartolome R. Celli & Caroline A. Owen
Pages: 869-883
Published online: 11 Feb 2016
AbstractforClub Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD) | Full Text | References | PDF (1.6 MB)
  • 693 Views
  • 53 CrossRef citations
  • 0Altmetric
The role of Sema4D/CD100 as a therapeutic target for tumor microenvironments and for autoimmune, neuroimmune and bone diseases
Mingfu Wu, Jing Li, Qinglei Gao & Fei Ye
Pages: 885-901
Published online: 28 Jan 2016
AbstractforThe role of Sema4D/CD100 as a therapeutic target for tumor microenvironments and for autoimmune, neuroimmune and bone diseases | Full Text | References | PDF (1.7 MB)
  • 749 Views
  • 23 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Fatty liver disease: time to target CCR5?
Vlad Dumitru Brata et al.
Editorial | Published online: 13 Jun 2024
Free Access
Targeting HIF-1α in sickle cell disease and cancer: unravelling therapeutic opportunities and risks.
Saba Ubaid et al.
Review Article | Published online: 11 Jun 2024
Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies
Harry Ridgway et al.
Article | Published online: 7 Jun 2024
New targets and mechanisms of action for lipid-lowering and anti-inflammatory therapies in atherosclerosis: where does the field stand?
Stephen J Nicholls et al.
Review Article | Published online: 4 Jun 2024
View all latest articles